A California company called PainVox has been helping clinicians identify the source of chronic pain. Two new injectable devices will soon be on the market as alternatives to Curonix. The company also announced additional reimbursement from CMS. The acquisition will give the company two different approaches to treating dry AMD. Blue Arbor Seeks to Take Control of Neuroprosthetics Market. Neurotech Execs Gather in NYC for Bioelectronic Medicine Forum. USC Center for Neurotechnology Exploits Machine Learning.
April 2024 Issue
Radiotracer Technology Helps Enable Pain Visualization
Injectable Neurostimulators Promise to Transform PNS Market
Magnus Medical Announces Commercial Launch of SAINT
Science Corp. Acquires Assets of Failed Pixium Vision
Vendor Profile
Conference Report
Research Institution Profile
Publishers Letter
Financial News
News Briefs
Research Highlights